SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cell Genesys (CEGE)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Mama Bear who wrote (886)4/25/2000 11:16:00 PM
From: david james  Read Replies (1) of 1298
 
CEGE retains 4.852 million shares of ABGX after the split. Today's ABGX earnings show 37.25 mill shares outstanding for ABGX. That would make over 12%. Does someone see more shares outstanding?

The 4.852 mill shares at $85 are worth $412 million.

With the sort of gain expected last quarter, I don't think they were in a hurry to put in any extra sources of income. With payments from JT expected this next quarter along with the interest, I suspect we will see a profit this quarter.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News